HEADER HYDROLASE/HYDROLASE INHIBITOR 07-DEC-14 4X68 TITLE CRYSTAL STRUCTURE OF OP0595 COMPLEXED WITH AMPC COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 32-387; COMPND 5 SYNONYM: CEPHALOSPORINASE; COMPND 6 EC: 3.5.2.6; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 208964; SOURCE 4 STRAIN: ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228; SOURCE 5 GENE: AMPC, PA4110; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.YAMADA,T.WATANABE REVDAT 3 05-FEB-20 4X68 1 REMARK REVDAT 2 14-OCT-15 4X68 1 JRNL REVDAT 1 01-JUL-15 4X68 0 JRNL AUTH A.MORINAKA,Y.TSUTSUMI,M.YAMADA,K.SUZUKI,T.WATANABE,T.ABE, JRNL AUTH 2 T.FURUUCHI,S.INAMURA,Y.SAKAMAKI,N.MITSUHASHI,T.IDA, JRNL AUTH 3 D.M.LIVERMORE JRNL TITL OP0595, A NEW DIAZABICYCLOOCTANE: MODE OF ACTION AS A SERINE JRNL TITL 2 BETA-LACTAMASE INHIBITOR, ANTIBIOTIC AND BETA-LACTAM JRNL TITL 3 'ENHANCER' JRNL REF J.ANTIMICROB.CHEMOTHER. V. 70 2779 2015 JRNL REFN ESSN 1460-2091 JRNL PMID 26089439 JRNL DOI 10.1093/JAC/DKV166 REMARK 2 REMARK 2 RESOLUTION. 1.68 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC_5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.68 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 67948 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 3308 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5546 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 242 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.89 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.09000 REMARK 3 B22 (A**2) : -1.53000 REMARK 3 B33 (A**2) : 0.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.24000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.137 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.128 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.094 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.801 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 4X68 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1000205006. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : ROTATED-INCLINED DOUBLE-CRYSTAL REMARK 200 MONOCHROMATOR , SI (111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX225HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 67982 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.680 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.68 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.56400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2WZX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.95 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 2000 MONOMETHYLETHER, NICL2, PH REMARK 280 8.5, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.39050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 249 14.48 -160.03 REMARK 500 GLU A 269 -7.88 -53.89 REMARK 500 ASN A 368 39.30 -96.94 REMARK 500 TYR B 249 17.25 -158.04 REMARK 500 ASN B 368 39.72 -98.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NI A 403 NI REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 149 OD2 REMARK 620 2 HIS B 267 NE2 77.2 REMARK 620 3 ASP B 360 OD1 67.0 65.3 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OP0 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NI A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NI A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide OP0 B 401 and SER B REMARK 800 90 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4X69 RELATED DB: PDB DBREF 4X68 A 32 387 UNP P24735 AMPC_PSEAE 32 387 DBREF 4X68 B 32 387 UNP P24735 AMPC_PSEAE 32 387 SEQADV 4X68 MET A 31 UNP P24735 INITIATING METHIONINE SEQADV 4X68 MET B 31 UNP P24735 INITIATING METHIONINE SEQRES 1 A 357 MET ASP ARG LEU LYS ALA LEU VAL ASP ALA ALA VAL GLN SEQRES 2 A 357 PRO VAL MET LYS ALA ASN ASP ILE PRO GLY LEU ALA VAL SEQRES 3 A 357 ALA ILE SER LEU LYS GLY GLU PRO HIS TYR PHE SER TYR SEQRES 4 A 357 GLY LEU ALA SER LYS GLU ASP GLY ARG ARG VAL THR PRO SEQRES 5 A 357 GLU THR LEU PHE GLU ILE GLY SER VAL SER LYS THR PHE SEQRES 6 A 357 THR ALA THR LEU ALA GLY TYR ALA LEU THR GLN ASP LYS SEQRES 7 A 357 MET ARG LEU ASP ASP ARG ALA SER GLN HIS TRP PRO ALA SEQRES 8 A 357 LEU GLN GLY SER ARG PHE ASP GLY ILE SER LEU LEU ASP SEQRES 9 A 357 LEU ALA THR TYR THR ALA GLY GLY LEU PRO LEU GLN PHE SEQRES 10 A 357 PRO ASP SER VAL GLN LYS ASP GLN ALA GLN ILE ARG ASP SEQRES 11 A 357 TYR TYR ARG GLN TRP GLN PRO THR TYR ALA PRO GLY SER SEQRES 12 A 357 GLN ARG LEU TYR SER ASN PRO SER ILE GLY LEU PHE GLY SEQRES 13 A 357 TYR LEU ALA ALA ARG SER LEU GLY GLN PRO PHE GLU ARG SEQRES 14 A 357 LEU MET GLU GLN GLN VAL PHE PRO ALA LEU GLY LEU GLU SEQRES 15 A 357 GLN THR HIS LEU ASP VAL PRO GLU ALA ALA LEU ALA GLN SEQRES 16 A 357 TYR ALA GLN GLY TYR GLY LYS ASP ASP ARG PRO LEU ARG SEQRES 17 A 357 VAL GLY PRO GLY PRO LEU ASP ALA GLU GLY TYR GLY VAL SEQRES 18 A 357 LYS THR SER ALA ALA ASP LEU LEU ARG PHE VAL ASP ALA SEQRES 19 A 357 ASN LEU HIS PRO GLU ARG LEU ASP ARG PRO TRP ALA GLN SEQRES 20 A 357 ALA LEU ASP ALA THR HIS ARG GLY TYR TYR LYS VAL GLY SEQRES 21 A 357 ASP MET THR GLN GLY LEU GLY TRP GLU ALA TYR ASP TRP SEQRES 22 A 357 PRO ILE SER LEU LYS ARG LEU GLN ALA GLY ASN SER THR SEQRES 23 A 357 PRO MET ALA LEU GLN PRO HIS ARG ILE ALA ARG LEU PRO SEQRES 24 A 357 ALA PRO GLN ALA LEU GLU GLY GLN ARG LEU LEU ASN LYS SEQRES 25 A 357 THR GLY SER THR ASN GLY PHE GLY ALA TYR VAL ALA PHE SEQRES 26 A 357 VAL PRO GLY ARG ASP LEU GLY LEU VAL ILE LEU ALA ASN SEQRES 27 A 357 ARG ASN TYR PRO ASN ALA GLU ARG VAL LYS ILE ALA TYR SEQRES 28 A 357 ALA ILE LEU SER GLY LEU SEQRES 1 B 357 MET ASP ARG LEU LYS ALA LEU VAL ASP ALA ALA VAL GLN SEQRES 2 B 357 PRO VAL MET LYS ALA ASN ASP ILE PRO GLY LEU ALA VAL SEQRES 3 B 357 ALA ILE SER LEU LYS GLY GLU PRO HIS TYR PHE SER TYR SEQRES 4 B 357 GLY LEU ALA SER LYS GLU ASP GLY ARG ARG VAL THR PRO SEQRES 5 B 357 GLU THR LEU PHE GLU ILE GLY SER VAL SER LYS THR PHE SEQRES 6 B 357 THR ALA THR LEU ALA GLY TYR ALA LEU THR GLN ASP LYS SEQRES 7 B 357 MET ARG LEU ASP ASP ARG ALA SER GLN HIS TRP PRO ALA SEQRES 8 B 357 LEU GLN GLY SER ARG PHE ASP GLY ILE SER LEU LEU ASP SEQRES 9 B 357 LEU ALA THR TYR THR ALA GLY GLY LEU PRO LEU GLN PHE SEQRES 10 B 357 PRO ASP SER VAL GLN LYS ASP GLN ALA GLN ILE ARG ASP SEQRES 11 B 357 TYR TYR ARG GLN TRP GLN PRO THR TYR ALA PRO GLY SER SEQRES 12 B 357 GLN ARG LEU TYR SER ASN PRO SER ILE GLY LEU PHE GLY SEQRES 13 B 357 TYR LEU ALA ALA ARG SER LEU GLY GLN PRO PHE GLU ARG SEQRES 14 B 357 LEU MET GLU GLN GLN VAL PHE PRO ALA LEU GLY LEU GLU SEQRES 15 B 357 GLN THR HIS LEU ASP VAL PRO GLU ALA ALA LEU ALA GLN SEQRES 16 B 357 TYR ALA GLN GLY TYR GLY LYS ASP ASP ARG PRO LEU ARG SEQRES 17 B 357 VAL GLY PRO GLY PRO LEU ASP ALA GLU GLY TYR GLY VAL SEQRES 18 B 357 LYS THR SER ALA ALA ASP LEU LEU ARG PHE VAL ASP ALA SEQRES 19 B 357 ASN LEU HIS PRO GLU ARG LEU ASP ARG PRO TRP ALA GLN SEQRES 20 B 357 ALA LEU ASP ALA THR HIS ARG GLY TYR TYR LYS VAL GLY SEQRES 21 B 357 ASP MET THR GLN GLY LEU GLY TRP GLU ALA TYR ASP TRP SEQRES 22 B 357 PRO ILE SER LEU LYS ARG LEU GLN ALA GLY ASN SER THR SEQRES 23 B 357 PRO MET ALA LEU GLN PRO HIS ARG ILE ALA ARG LEU PRO SEQRES 24 B 357 ALA PRO GLN ALA LEU GLU GLY GLN ARG LEU LEU ASN LYS SEQRES 25 B 357 THR GLY SER THR ASN GLY PHE GLY ALA TYR VAL ALA PHE SEQRES 26 B 357 VAL PRO GLY ARG ASP LEU GLY LEU VAL ILE LEU ALA ASN SEQRES 27 B 357 ARG ASN TYR PRO ASN ALA GLU ARG VAL LYS ILE ALA TYR SEQRES 28 B 357 ALA ILE LEU SER GLY LEU HET OP0 A 401 21 HET NI A 402 1 HET NI A 403 1 HET OP0 B 401 21 HETNAM OP0 (2S,5R)-N-(2-AMINOETHOXY)-1-FORMYL-5-[(SULFOOXY) HETNAM 2 OP0 AMINO]PIPERIDINE-2-CARBOXAMIDE HETNAM NI NICKEL (II) ION FORMUL 3 OP0 2(C9 H18 N4 O7 S) FORMUL 4 NI 2(NI 2+) FORMUL 7 HOH *242(H2 O) HELIX 1 AA1 MET A 31 ASN A 49 1 19 HELIX 2 AA2 VAL A 91 GLN A 106 1 16 HELIX 3 AA3 ARG A 114 GLN A 123 5 10 HELIX 4 AA4 SER A 125 GLY A 129 5 5 HELIX 5 AA5 SER A 131 THR A 137 1 7 HELIX 6 AA6 ASP A 154 TRP A 165 1 12 HELIX 7 AA7 SER A 178 LEU A 193 1 16 HELIX 8 AA8 PRO A 196 GLN A 204 1 9 HELIX 9 AA9 GLN A 204 LEU A 209 1 6 HELIX 10 AB1 PRO A 219 TYR A 226 5 8 HELIX 11 AB2 LEU A 244 GLY A 250 1 7 HELIX 12 AB3 ALA A 255 HIS A 267 1 13 HELIX 13 AB4 PRO A 268 LEU A 271 5 4 HELIX 14 AB5 ASP A 272 THR A 282 1 11 HELIX 15 AB6 SER A 306 ASN A 314 1 9 HELIX 16 AB7 SER A 315 GLN A 321 1 7 HELIX 17 AB8 PRO A 357 ARG A 359 5 3 HELIX 18 AB9 PRO A 372 GLY A 386 1 15 HELIX 19 AC1 ASP B 32 ASN B 49 1 18 HELIX 20 AC2 VAL B 91 GLN B 106 1 16 HELIX 21 AC3 ARG B 114 GLN B 123 5 10 HELIX 22 AC4 SER B 125 GLY B 129 5 5 HELIX 23 AC5 SER B 131 THR B 137 1 7 HELIX 24 AC6 ASP B 154 TRP B 165 1 12 HELIX 25 AC7 SER B 178 LEU B 193 1 16 HELIX 26 AC8 PRO B 196 GLN B 204 1 9 HELIX 27 AC9 GLN B 204 LEU B 209 1 6 HELIX 28 AD1 PRO B 219 TYR B 226 5 8 HELIX 29 AD2 LEU B 244 TYR B 249 1 6 HELIX 30 AD3 ALA B 255 HIS B 267 1 13 HELIX 31 AD4 PRO B 268 LEU B 271 5 4 HELIX 32 AD5 ASP B 272 THR B 282 1 11 HELIX 33 AD6 SER B 306 ASN B 314 1 9 HELIX 34 AD7 SER B 315 GLN B 321 1 7 HELIX 35 AD8 PRO B 357 ARG B 359 5 3 HELIX 36 AD9 PRO B 372 GLY B 386 1 15 SHEET 1 AA1 9 GLU A 63 GLY A 70 0 SHEET 2 AA1 9 GLY A 53 LEU A 60 -1 N VAL A 56 O PHE A 67 SHEET 3 AA1 9 LEU A 361 ALA A 367 -1 O LEU A 366 N ALA A 55 SHEET 4 AA1 9 PHE A 349 VAL A 356 -1 N ALA A 354 O LEU A 363 SHEET 5 AA1 9 ARG A 338 THR A 346 -1 N GLY A 344 O ALA A 351 SHEET 6 AA1 9 GLU A 299 ASP A 302 -1 N TYR A 301 O LEU A 339 SHEET 7 AA1 9 MET A 292 GLN A 294 -1 N THR A 293 O ALA A 300 SHEET 8 AA1 9 ARG A 284 VAL A 289 -1 N TYR A 287 O GLN A 294 SHEET 9 AA1 9 ALA A 326 ALA A 333 -1 O GLN A 332 N GLY A 285 SHEET 1 AA2 3 LEU A 85 GLU A 87 0 SHEET 2 AA2 3 LYS A 252 SER A 254 -1 O THR A 253 N PHE A 86 SHEET 3 AA2 3 THR A 214 HIS A 215 -1 N HIS A 215 O LYS A 252 SHEET 1 AA3 2 GLN A 174 ARG A 175 0 SHEET 2 AA3 2 HIS A 323 ARG A 324 -1 O HIS A 323 N ARG A 175 SHEET 1 AA4 2 GLY A 229 TYR A 230 0 SHEET 2 AA4 2 PRO A 236 LEU A 237 -1 O LEU A 237 N GLY A 229 SHEET 1 AA5 9 GLU B 63 GLY B 70 0 SHEET 2 AA5 9 GLY B 53 LEU B 60 -1 N VAL B 56 O PHE B 67 SHEET 3 AA5 9 LEU B 361 ALA B 367 -1 O GLY B 362 N SER B 59 SHEET 4 AA5 9 GLY B 350 VAL B 356 -1 N ALA B 354 O LEU B 363 SHEET 5 AA5 9 ARG B 338 SER B 345 -1 N GLY B 344 O ALA B 351 SHEET 6 AA5 9 GLU B 299 ASP B 302 -1 N TYR B 301 O LEU B 339 SHEET 7 AA5 9 MET B 292 GLN B 294 -1 N THR B 293 O ALA B 300 SHEET 8 AA5 9 ARG B 284 VAL B 289 -1 N TYR B 287 O GLN B 294 SHEET 9 AA5 9 ALA B 326 ALA B 333 -1 O GLN B 332 N GLY B 285 SHEET 1 AA6 2 LEU B 85 GLU B 87 0 SHEET 2 AA6 2 LYS B 252 SER B 254 -1 O THR B 253 N PHE B 86 SHEET 1 AA7 2 GLN B 174 ARG B 175 0 SHEET 2 AA7 2 HIS B 323 ARG B 324 -1 O HIS B 323 N ARG B 175 SHEET 1 AA8 2 GLY B 229 TYR B 230 0 SHEET 2 AA8 2 PRO B 236 LEU B 237 -1 O LEU B 237 N GLY B 229 LINK OG SER A 90 C1 OP0 A 401 1555 1555 1.36 LINK OD2 ASP A 149 NI NI A 403 1555 1555 2.76 LINK OD2 ASP A 360 NI NI A 402 1555 1555 2.32 LINK OG SER B 90 C1 OP0 B 401 1555 1555 1.36 LINK NE2 HIS B 267 NI NI A 403 1555 1555 2.56 LINK OD1 ASP B 360 NI NI A 403 1555 1555 2.65 CISPEP 1 TRP A 303 PRO A 304 0 6.94 CISPEP 2 TRP B 303 PRO B 304 0 4.07 SITE 1 AC1 14 SER A 90 GLN A 146 TYR A 177 ASN A 179 SITE 2 AC1 14 TYR A 249 LYS A 342 THR A 343 GLY A 344 SITE 3 AC1 14 SER A 345 ASN A 373 HOH A 572 HOH A 605 SITE 4 AC1 14 HOH A 620 HOH A 621 SITE 1 AC2 2 HIS A 267 ASP A 360 SITE 1 AC3 3 ASP A 149 HIS B 267 ASP B 360 SITE 1 AC4 18 ILE B 88 GLY B 89 VAL B 91 SER B 92 SITE 2 AC4 18 LYS B 93 GLN B 146 TYR B 177 ASN B 179 SITE 3 AC4 18 GLY B 248 TYR B 249 LYS B 342 THR B 343 SITE 4 AC4 18 GLY B 344 SER B 345 ASN B 373 HOH B 668 SITE 5 AC4 18 HOH B 713 HOH B 714 CRYST1 74.027 54.781 75.667 90.00 90.80 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013509 0.000000 0.000188 0.00000 SCALE2 0.000000 0.018255 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013217 0.00000 MASTER 243 0 4 36 31 0 11 6 0 0 0 56 END